Dr. Reddy's Laboratories has received approval from U.S. Food and Drug Administration (USFDA) for its rituximab biosimilar, a biosimilar to Rituxan (rituximab), for the U.S. market. The approval further strengthens its growing global biosimilars portfolio and advances its biosimilars business in the United States. Rituximab is a monoclonal antibody that selectively targets the CD20 protein expressed on B-cells. By binding to CD20, rituximab induces B-cell depletion through multiple immune-mediated mechanisms.
Escorts Kubota’s Agri Machinery Business has sold 8,731 tractors in July 2026, registering a growth of 22.0% as against 7,154 tractors sold in July 2025. Domestic tractor sales in July 2026 were at 8,194 tractors, registering a growth of 23.7% as against 6,624 tractors in July 2025. Meanwhile, export tractor sales in July 2026 stood at 537 tractors, registering a growth of 1.3% as against 530 tractors sold in July 2025.
Mahindra & Mahindra’s (M&M) Farm Equipment Business has reported total tractor sales of 34,420 units in July 2026, registering a growth of 20% as compared with 28,708 units in July 2025. Domestic tractor sales stood at 32,643 units in July 2026, as compared with 26,990 units in July 2025, registering a growth of 21%. Exports increased 3% to 1,777 units in July 2026 from 1,718 units in July 2025.
Maruti Suzuki India has reported a 33.73% rise in total sales (Domestic + Export) to 2,41,421 units in July 2026 as compared to sales of 1,80,526 units in July 2025. Total domestic vehicle sales, including light commercial vehicles (LCV), grew 42.37% to 2,00,123 units in July 2026 as compared to 1,40,570 units in the same month last year.
NCC has received three orders aggregating to Rs 1052.71 crore (excl. GST), during the month of July 2026. Of these orders received, Rs 590.38 crore pertains to the buildings division and Rs 462.33 crore pertains to the water division of the company.
SML Mahindra has reported total sales of 1603 units in July 2026, registering a growth of 12% compared to 1427 units sold in July 2025. The growth was primarily driven by the Passenger Vehicles category, where sales increased by 21% to 1186 units in July 2026 from 978 units in the corresponding month last year. However, Cargo Vehicles sales declined 7% to 417 units in July 2026 from 449 units a year ago month.
GAIL (India) has reported a 96.92% rise in its consolidated net profit at Rs 4,665.36 crore for Q1FY27, as compared to Rs 2,369.20 crore for the same quarter in the previous year. Total income increased by 16.61% to Rs 41,482.65 crore for Q1FY27 as compared to Rs 35,572.94 crore for the corresponding quarter of the previous year.
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through:
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
|
Name of the IA registered
with SEBI: |
The Alchemists Ark Pvt. Ltd. |
|
Logo:
|
|
|
Trade/Brand
Name of IA: |
MoneyWorks4Me Investment Advisers |
|
Brand Logo:
|
 |
|
SEBI Registration Number:
|
INA000013323 Validity – May 16, 2019 – Perpetual |
|
Registration:
|
Non-Individual |
|
BSE Enlistment No:
|
1187 |
|
Address:
|
B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045 |
|
Compliance Officer
Details: |
Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com |
Telephone: +919860359463 Address: Same as IA |
|
Grievance Officer
Details: |
Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com |
Telephone: +919860919463 Address: Same as IA |
|
Principal Officer
Details: |
Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com |
Telephone: +919175899463 Address: Same as IA |
|
Standard Warning:
|
Investment in securities market are subject to market risks. Read all the related documents carefully before investing. |
|
|
Disclaimer:
|
Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. |
|
